ASH2L drives proliferation and sensitivity to bleomycin and other genotoxins in Hodgkin's lymphoma and testicular cancer cells
The paper identifies ASH2L as a biomarker for predicting response to genotoxins in Hodgkin's lymphoma and testicular cancer, showing its role in proliferation and sensitivity to DNA damaging drugs.
bioRxiv · Aug 12, 2020Cancer Biology